Global spine biologics market set to grow through 2024 — 4 observations

Spinal Tech

The global spine biologics market will grow through 2024, based on a Transparency Market Research report, according to medGadget.

Here are four observations:

 

1. Biologics' popularity among spine surgeons will drive the market, along with the minimally invasive nature of the procedure and a growing geriatric population.


2. Currently, North America holds the largest market share, with Europe coming in second, due to advanced technologies and high per capita income.

 

3. The Asian-Pacific market is set to grow at a high rate because of an increasing population, better medical coverage and growing demand in India and China.

 

4. Key market players include Alphatec Spine, DePuy Synthes, Medtronic, Stryker, Smith & Nephew, Orthovita, Zimmer Biomet, K2M, NuVasive, Lattice Biologics, Arthrex, DMP Spine, Orthofix, RTI Surgical, Wright Medical Technology, Cesca Therapeutics and Precision Spine.

 

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers